Cholesgen Pharmaceutical
PrivateLast Round
Series A
Extension
Feb 21, 2025
Total Funding Raised
$28M
Company Overview
Cholesgen Pharmaceutical is a biopharmaceutical company that develops innovative drugs for metabolic diseases, such as hyperlipidemia, obesity, diabetes, atherosclerosis, and NASH, as well as oncology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cholesgen Pharmaceutical Comparables
Compare Cholesgen Pharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rona Therapeutics | 78% | |
| MindRank | 77% | |
| Lime Therapeutics | 74% |
Cholesgen Pharmaceutical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 21, 2025 | ||||
| Series A | May 30, 2023 | ||||
| Angel | Apr 1, 2021 |
Cholesgen Pharmaceutical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CICC Capital | Series A |
| Trinity Innovation Fund | Series A, Angel |
| SDIC Venture Capital | Series A Extension |
| Gaorong Capital | Series A |
| Trinity Innovation Fund | Angel, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 21, 2025
$14M round led by SDIC Venture Capital
- Apr 1, 2021
Trinity Innovation Fund led the round.
Cholesgen Pharmaceutical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cholesgen Pharmaceutical's valuation, stock price, and market status.
Is Cholesgen Pharmaceutical a public or private company?
Cholesgen Pharmaceutical is a private company.
What is the current stock price of Cholesgen Pharmaceutical?
Cholesgen Pharmaceutical is a private company with no public stock price. No recent secondary market data is available.
How much is Cholesgen Pharmaceutical worth (valuation)?
Valuation information for Cholesgen Pharmaceutical is not publicly available.
Can I buy Cholesgen Pharmaceutical stock?
Cholesgen Pharmaceutical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cholesgen Pharmaceutical's last funding round?
Cholesgen Pharmaceutical's most recent funding round was Series A Extension on February 21, 2025.
Who are the main investors in Cholesgen Pharmaceutical?
Key investors in Cholesgen Pharmaceutical include Trinity Innovation Fund, SDIC Venture Capital, Gaorong Capital.
Will Cholesgen Pharmaceutical IPO soon?
No public IPO plans have been announced for Cholesgen Pharmaceutical.
How can I track Cholesgen Pharmaceutical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cholesgen Pharmaceutical's secondary market activity and sign up for updates.